Thyme Care CEO Robin Shah (L) and CMO Bobby Green
July 17, 2024 12:02 PM EDTUpdated 12:59 PM
Financing
Startups
Health Tech

Thyme Care scores $480M val­u­a­tion in new fund­ing round

Shelby Livingston

Senior health tech reporter

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

Thyme Care’s lat­est …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times